Pandorum Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$18M
- Investors
-
41
Pandorum General Information
Description
Developer of functional human tissues designed for tissue engineering and regenerative medicine. The company's experimental-stage human liver tissue is created using three-dimensional printing technology and acts as an artificial liver during liver failures or liver transplantation, and takes less time to regenerate for medical research and therapeutic applications, enabling surgeons to perform painless liver surgeries to advance regenerative therapies.
Contact Information
Website
www.pandorum.comCorporate Office
- EGF 5, Bangalore Bioinnovation Centre
- Bangalore Helix Biotech Park, Electronics City Phase 1
- Bengaluru, Karnataka 560100
- India
Corporate Office
- EGF 5, Bangalore Bioinnovation Centre
- Bangalore Helix Biotech Park, Electronics City Phase 1
- Bengaluru, Karnataka 560100
- India
Pandorum Timeline
Pandorum Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC (Series B) | 09-Feb-2026 | $18M | Completed | Generating Revenue | ||
| 13. Later Stage VC (Series A) | 15-Mar-2024 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 14-Oct-2022 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 20-Oct-2021 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series B) | 08-Sep-2020 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series A) | 13-Feb-2018 | Completed | Product Development | |||
| 8. Angel (individual) | 24-Dec-2016 | Completed | Startup | |||
| 7. Grant | 01-Jan-2014 | Completed | Startup | |||
| 6. Grant | 01-Jan-2012 | $100K | $450K | Completed | Startup | |
| 5. Angel (individual) | $400K | $450K | Completed | Startup |
Pandorum Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 CCPS | ||||||||
| Series A1 CCPS | ||||||||
| Ordinary Shares | ||||||||
| Preferance Shares | ||||||||
| Preferance Shares | ||||||||
| Preferance Shares | 36,457 | $14.199461 | $72.14 | $72.14 | 1x | $72.14 | 14.14% | |
| Ordinary Shares | 8,702 | $0.012064 | $27.72 | $27.72 | 1x | $27.72 | 3.37% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Pandorum Comparisons
Industry
Financing
Details
Pandorum Competitors (6)
One of Pandorum’s 6 competitors is Aspect Biosystems, a Venture Capital-Backed company based in Vancouver, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aspect Biosystems | Venture Capital-Backed | Vancouver, Canada | ||||
| InSphero | Private Equity-Backed | Schlieren, Switzerland | ||||
| VivoSim Labs | Formerly VC-backed | San Diego, CA | ||||
| Synthecon | Formerly Accelerator/Incubator backed | Houston, TX | ||||
| Prothena | Corporation | Dublin, Ireland |
Pandorum Patents
Pandorum Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026036123-A1 | A corneal implant and process of preparation thereof | Pending | 08-Aug-2024 | ||
| WO-2025259683-A1 | Machine learning based assessment of biological and synthetic nanovesicles | Pending | 10-Jun-2024 | ||
| WO-2025251061-A1 | Method for scalable production of therapeutic exosomes | Pending | 31-May-2024 | ||
| WO-2025251061-A9 | Method for scalable production of therapeutic exosomes | Pending | 31-May-2024 | ||
| EP-4820075-A1 | A lenticule, method of preparation and implementations thereof | Pending | 04-Dec-2023 | A61L27/26 |
Pandorum Signals
Pandorum Investors (41)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aeroflex Enterprises | Venture Capital | Minority | ||
| Auraplus Services | Corporation | Minority | ||
| Avinya Ventures | Venture Capital | Minority | ||
| Burman Family | Family Office | Minority | ||
| Galentic Pharma (India) Pvt. | Corporation | Minority |
Pandorum FAQs
-
When was Pandorum founded?
Pandorum was founded in 2009.
-
Where is Pandorum headquartered?
Pandorum is headquartered in Bengaluru, India.
-
What is the size of Pandorum?
Pandorum has 40 total employees.
-
What industry is Pandorum in?
Pandorum’s primary industry is Biotechnology.
-
Is Pandorum a private or public company?
Pandorum is a Private company.
-
What is Pandorum’s current revenue?
The current revenue for Pandorum is .
-
How much funding has Pandorum raised over time?
Pandorum has raised $43.7M.
-
Who are Pandorum’s investors?
Aeroflex Enterprises, Auraplus Services, Avinya Ventures, Burman Family, and Galentic Pharma (India) Pvt. are 5 of 41 investors who have invested in Pandorum.
-
Who are Pandorum’s competitors?
Aspect Biosystems, InSphero, VivoSim Labs, Synthecon, and Prothena are some of the 6 competitors of Pandorum.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process